-
1
-
-
50449099518
-
Pemphigus
-
Wolff K, Goldsmith L, Katz S, Gilchrest B A, Paller A, Leffel D. In, eds, 7th edn, New York, McGraw-Hill
-
Stanley J R. Pemphigus. Fritzpatrik's Dermatology in General Medicine 2007, 459-467. Wolff KGoldsmith LKatz SGilchrest B APaller ALeffel D. In, eds, 7th edn, New York, McGraw-Hill
-
(2007)
Fritzpatrik's Dermatology in General Medicine
, pp. 459-467
-
-
Stanley, J.R.1
-
2
-
-
49349087524
-
Pemphigus: a complex T cell-dependent autoimmune disorder leading to acantholysis
-
Veldman C, Feliciani C. Pemphigus: a complex T cell-dependent autoimmune disorder leading to acantholysis. Clin Rev Allergy Immunol 2008, 34:313-320.
-
(2008)
Clin Rev Allergy Immunol
, vol.34
, pp. 313-320
-
-
Veldman, C.1
Feliciani, C.2
-
3
-
-
3242762566
-
A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice
-
Aoki-Ota M, Tsunoda K, Ota T. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice. Br J Dermatol 2004, 151:346-354.
-
(2004)
Br J Dermatol
, vol.151
, pp. 346-354
-
-
Aoki-Ota, M.1
Tsunoda, K.2
Ota, T.3
-
4
-
-
46749139507
-
Treatment strategies for pemphigus vulgaris in Japan
-
Hashimoto T. Treatment strategies for pemphigus vulgaris in Japan. Expert Opin Pharmacother 2008, 9:1519-1530.
-
(2008)
Expert Opin Pharmacother
, vol.9
, pp. 1519-1530
-
-
Hashimoto, T.1
-
5
-
-
70349429842
-
Randomized open comparative trials of dexamethason-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris
-
Sethy P K, Khandpur S, Sharma V K. Randomized open comparative trials of dexamethason-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris. Indian J Dermatol Venereol Leprol 2009, 75:476-482.
-
(2009)
Indian J Dermatol Venereol Leprol
, vol.75
, pp. 476-482
-
-
Sethy, P.K.1
Khandpur, S.2
Sharma, V.K.3
-
6
-
-
67749088587
-
Outcome of dexamethason-cyclophosphamide pulse therapy in pemphigus: a case series
-
Khanda S, Thappa D M. Outcome of dexamethason-cyclophosphamide pulse therapy in pemphigus: a case series. Indian J Dermatol Venereol Leprol 2009, 75:373-378.
-
(2009)
Indian J Dermatol Venereol Leprol
, vol.75
, pp. 373-378
-
-
Khanda, S.1
Thappa, D.M.2
-
8
-
-
60549101871
-
Diagnosis of autoimmune bullous skin diseases
-
Zillikens D. Diagnosis of autoimmune bullous skin diseases. Clin Lab 2008, 54:491-503.
-
(2008)
Clin Lab
, vol.54
, pp. 491-503
-
-
Zillikens, D.1
-
9
-
-
0033557198
-
Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris
-
Mahoney M G, Wang Z, Rothenberger K, Koch P J, Amagai M, Stanley J R. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999, 103:461-468.
-
(1999)
J Clin Invest
, vol.103
, pp. 461-468
-
-
Mahoney, M.G.1
Wang, Z.2
Rothenberger, K.3
Koch, P.J.4
Amagai, M.5
Stanley, J.R.6
-
10
-
-
0025789652
-
Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion
-
Amagai M, Klaus-Kovtun V, Stanley J R. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991, 67:869-877.
-
(1991)
Cell
, vol.67
, pp. 869-877
-
-
Amagai, M.1
Klaus-Kovtun, V.2
Stanley, J.R.3
-
11
-
-
0036378082
-
Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3
-
Cheng S W, Kobayashi M, Kinoshita-Kuroda K, Tanikawa A, Amagai M, Nishikawa T. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. Br J Dermatol 2002, 147:261-265.
-
(2002)
Br J Dermatol
, vol.147
, pp. 261-265
-
-
Cheng, S.W.1
Kobayashi, M.2
Kinoshita-Kuroda, K.3
Tanikawa, A.4
Amagai, M.5
Nishikawa, T.6
-
12
-
-
0031571268
-
Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins
-
Ishii K, Amagai M, Hall R P. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 1997, 159:2010-2017.
-
(1997)
J Immunol
, vol.159
, pp. 2010-2017
-
-
Ishii, K.1
Amagai, M.2
Hall, R.P.3
-
13
-
-
37249063047
-
IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris
-
Müller R, Svoboda V, Wenzel E, Müller H H, Hertl M. IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris. Exp Dermatol 2008, 17:35-43.
-
(2008)
Exp Dermatol
, vol.17
, pp. 35-43
-
-
Müller, R.1
Svoboda, V.2
Wenzel, E.3
Müller, H.H.4
Hertl, M.5
-
14
-
-
67651184451
-
Interventions for pemphigus vulgaris and pemphigus foliaceus
-
Martin L K, Werth V, Villanueva E, Segall J, Murrell D F. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database 2008, http://mrw.interscience.wiley.com/cochrane
-
(2008)
Cochrane Database
-
-
Martin, L.K.1
Werth, V.2
Villanueva, E.3
Segall, J.4
Murrell, D.F.5
-
15
-
-
44049086991
-
Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases
-
Hertl M, Zillikens D, Borradori L. Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases. J Dtsch Dermatol Ges 2008, 6:366-373.
-
(2008)
J Dtsch Dermatol Ges
, vol.6
, pp. 366-373
-
-
Hertl, M.1
Zillikens, D.2
Borradori, L.3
-
16
-
-
0021195709
-
Adjuvant therapy of pemphigus
-
Bystryn J C. Adjuvant therapy of pemphigus. Arch Dermatol 1984, 120:941-951.
-
(1984)
Arch Dermatol
, vol.120
, pp. 941-951
-
-
Bystryn, J.C.1
-
17
-
-
0034116198
-
Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus
-
Amagai M, Tsunoda K, Suzuki H, Nishifuji K, Koyasu S, Nishikawa T. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J Clin Invest 2000, 105:625-631.
-
(2000)
J Clin Invest
, vol.105
, pp. 625-631
-
-
Amagai, M.1
Tsunoda, K.2
Suzuki, H.3
Nishifuji, K.4
Koyasu, S.5
Nishikawa, T.6
-
18
-
-
49049114366
-
Pemphigus vulgaris and its active disease mouse model
-
Amagai M. Pemphigus vulgaris and its active disease mouse model. Curr Dir Autoimmun 2008, 10:167-181.
-
(2008)
Curr Dir Autoimmun
, vol.10
, pp. 167-181
-
-
Amagai, M.1
-
19
-
-
40649098266
-
Experimental autoimmune encephalomyelitis (EAE) induced by antigen pulsed dendritic cells in the C57BL/6 mouse: influence of injection route
-
Aghdami N, Gharibdoost F, Moazzeni S M. Experimental autoimmune encephalomyelitis (EAE) induced by antigen pulsed dendritic cells in the C57BL/6 mouse: influence of injection route. Exp Anim 2008, 57:45-55.
-
(2008)
Exp Anim
, vol.57
, pp. 45-55
-
-
Aghdami, N.1
Gharibdoost, F.2
Moazzeni, S.M.3
-
20
-
-
0027943962
-
Targeting of pancreatic islets of severe combined immunodeficient mice by passive transfer of allogeneic spleen cells from non-obese diabetic mice
-
Reddy S, Liu W, Elliott R B. Targeting of pancreatic islets of severe combined immunodeficient mice by passive transfer of allogeneic spleen cells from non-obese diabetic mice. Immunol Cell Biol 1994, 72:390-397.
-
(1994)
Immunol Cell Biol
, vol.72
, pp. 390-397
-
-
Reddy, S.1
Liu, W.2
Elliott, R.B.3
-
21
-
-
64549114217
-
Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies
-
Takae Y, Nishikawa T, Amagai M. Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies. Exp Dermatol 2008, 18:252-260.
-
(2008)
Exp Dermatol
, vol.18
, pp. 252-260
-
-
Takae, Y.1
Nishikawa, T.2
Amagai, M.3
-
22
-
-
0030902370
-
Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris
-
Koch P J, Mahoney M G, Ishikawa H. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 1997, 137:1091-1102.
-
(1997)
J Cell Biol
, vol.137
, pp. 1091-1102
-
-
Koch, P.J.1
Mahoney, M.G.2
Ishikawa, H.3
-
23
-
-
0017184389
-
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
-
Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
-
(1976)
Anal Biochem
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
-
24
-
-
0036209714
-
Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris
-
Tsunoda K, Ota T, Suzuki H. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris. Eur J Immunol 2002, 32:627-633.
-
(2002)
Eur J Immunol
, vol.32
, pp. 627-633
-
-
Tsunoda, K.1
Ota, T.2
Suzuki, H.3
-
25
-
-
16844380687
-
In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris
-
Ishii K, Harada R, Matsuo I, Shirakata Y, Hashimoto K, Amagai M. In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris. J Invest Dermatol 2005, 124:939-946.
-
(2005)
J Invest Dermatol
, vol.124
, pp. 939-946
-
-
Ishii, K.1
Harada, R.2
Matsuo, I.3
Shirakata, Y.4
Hashimoto, K.5
Amagai, M.6
-
26
-
-
33751103915
-
Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation
-
Kawasaki H, Tsunoda K, Hata T, Ishii K, Yamada T, Amagai M. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation. J Invest Dermatol 2006, 126:2621-2630.
-
(2006)
J Invest Dermatol
, vol.126
, pp. 2621-2630
-
-
Kawasaki, H.1
Tsunoda, K.2
Hata, T.3
Ishii, K.4
Yamada, T.5
Amagai, M.6
-
27
-
-
0037442123
-
Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3
-
Tsunoda K, Ota T, Aoki M. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 2003, 170:2170-2178.
-
(2003)
J Immunol
, vol.170
, pp. 2170-2178
-
-
Tsunoda, K.1
Ota, T.2
Aoki, M.3
-
28
-
-
63149093146
-
A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris
-
Takahashi H, Kuwana M, Amagai M. A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris. J Immunol 2009, 182:1740-1745.
-
(2009)
J Immunol
, vol.182
, pp. 1740-1745
-
-
Takahashi, H.1
Kuwana, M.2
Amagai, M.3
-
29
-
-
49049104862
-
Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris
-
Takahashi H, Amagai M, Nishikawa T, Fujii Y, Kawakami Y, Kuwana M. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris. J Immunol 2008, 181:1526-1535.
-
(2008)
J Immunol
, vol.181
, pp. 1526-1535
-
-
Takahashi, H.1
Amagai, M.2
Nishikawa, T.3
Fujii, Y.4
Kawakami, Y.5
Kuwana, M.6
-
30
-
-
34248150428
-
The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases
-
Sitaru C, Mihai S, Zillikens D. The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases. Arch Dermatol Res 2007, 299:1-8.
-
(2007)
Arch Dermatol Res
, vol.299
, pp. 1-8
-
-
Sitaru, C.1
Mihai, S.2
Zillikens, D.3
-
31
-
-
0029096566
-
Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent
-
Amagai M, Ishii K, Hashimoto T, Gamou S, Shimizu N, Nishikawa T. Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. J Invest Dermatol 1995, 105:243-247.
-
(1995)
J Invest Dermatol
, vol.105
, pp. 243-247
-
-
Amagai, M.1
Ishii, K.2
Hashimoto, T.3
Gamou, S.4
Shimizu, N.5
Nishikawa, T.6
-
32
-
-
33646411527
-
T cell control in autoimmune bullous skin disorders
-
Hertl M, Eming R, Veldman C. T cell control in autoimmune bullous skin disorders. J Clin Invest 2006, 116:1159-1166.
-
(2006)
J Clin Invest
, vol.116
, pp. 1159-1166
-
-
Hertl, M.1
Eming, R.2
Veldman, C.3
|